INHIBITION OF CELLULAR INVASION AND INDUCTION OF ANOIKIS IN MOUSE MELANOMA CELLS BY AN ANTI-INFLAMMATORY AGENT DTCM-GLUTARIMIDE

Previously, we designed DTCM-glutarimide as a novel anti-inflammatory agent inhibiting macrophage activation. It also showed anti-inflammatory activity in vivo. In the present research, we evaluated the  anti-metastatic activity of this agent using  mouse  melanoma B16-F10 cells. DTCM-glutarimide in...

Full description

Bibliographic Details
Main Authors: A. Kaneda, Sh. Kh. Gantsev, K. Umezawa
Format: Article
Language:English
Published: Bashkir State Medical University 2017-01-01
Series:Креативная хирургия и онкология
Subjects:
bax
p53
Online Access:https://www.surgonco.ru/jour/article/view/123